B-cell activation and allosensitization after left ventricular assist device implantation is due to T-cell activation and CD40 ligand expression

Keyphrases

• Left Ventricular Assist Device 100%
• Allosensitization 100%
• T Cell Activation 100%
• B Cell Activation 100%
• CD40 Ligand (CD40L) 100%
• Left Ventricular Assist Device Implantation 100%
• T Cells 66%
• Biomaterials 50%
• B Cells 33%
• T-cell Mediated 33%
• NFATc1 33%
• HLA Antibodies 33%
• Nuclear Translocation 33%
• Soluble CD40 Ligand 33%
• Calcium Flux 33%
• Hyperreactivity 33%
• Heart Failure 16%
• Monoclonal Antibody 16%
• Calcineurin 16%
• Calcineurin Inhibitors 16%
• CD40 16%
• Transplant Outcomes 16%
• CD25 16%
• Anti-CD40 16%
• Significant Risk Factors 16%
• Cellular Expression 16%
• Flow Cytometry 16%
• Serum Levels 16%
• Mononuclear Cells 16%
• Alloantibody 16%
• Antibody Level 16%
• Anti-CD25 16%
• Ligand Interaction 16%
• Cell Calcium 16%
• Failure Control 16%
• Inhibitor Antibodies 16%

Immunology and Microbiology

• T Cell Activation 100%
• B Cell Activation 100%
• CD40 Ligand 100%
• T Cell 71%
• B Cell 28%
• CD25 28%
• Calcium Transport 28%
• HLA Antibody 28%
• Monoclonal Antibody 14%
• Blood Level 14%
• Mononuclear Cell 14%
• Calcium Cell Level 14%
• Alloantibody 14%

Pharmacology, Toxicology and Pharmaceutical Science

• CD40 Ligand 100%
• Biomaterial 42%
• HLA Antibody 28%
• Flow Cytometry 14%
• Calcineurin Inhibitor 14%
• Congestive Heart Failure 14%
• Monoclonal Antibody 14%
• Calcineurin 14%
• Alloantibody 14%